SBIR-STTR Award

Sequencing of Epigenetic Modifications from Single Cells
Award last edited on: 4/11/2016

Sponsored Program
SBIR
Awarding Agency
NIH : NHGRI
Total Award Amount
$298,940
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Masoud Toloue

Company Information

Bioo Scientific Corporation

7050 Burleson Road
Austin, TX 78744
   (512) 707-8993
   info@biooscientific.com
   www.biooscientific.com
Location: Single
Congr. District: 35
County: Travis

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2016
Phase I Amount
$298,940
DNA methylation has been shown to be associated with cancer, inflammatory and metabolic disorders, neuronal plasticity and memory formation. Up to now, DNA methylation has been largely studied by whole genome bisulfite sequencing of populations of cells. Studies like the Epigenomics Project and the 1000 Genomes Projects have contributed significantly to our understanding of genetic, phenotypic and epigenetic variations amongst individuals in a population. However, all of these studies are essentially averaged snapshots or normalized fixed time assessments of our genetic and epigenetic makeup. Nowhere is it more important to study dynamic variation than in epigenomics. Almost all our understanding of the epigenome and its regulation has been derived from studies carried out at the population level - thousands of cells being sequenced together. There is considerable evidence indicating that cell to cell variability in gene expression is ubiquitous, even amongst 'homogeneous" populations of cells. The extent of epigenetic heterogeneity in diverse cell types in tissues remains largely unknown. Our goal in this grant application is to develop a solution to this problem by developing at least two single cell methyl-sequencing library preparation protocols that will allow investigators to interrogate epigenetic modifications amongst individual cells of a population.

Public Health Relevance Statement:


Public Health Relevance:
DNA methylation has been shown to be associated with cancer, inflammatory and metabolic disorders, neuronal plasticity and memory formation. Up to now, DNA methylation has been largely studied by whole genome sequencing populations of cells. Our goal is to develop technology that allows for the examination of methylation patterns and stochastic intercellular variation in the epigenomes of single cells.

Project Terms:
Accounting; Applications Grants; base; Binding (Molecular Function); bisulfite; bisulfite sequencing; Brain; brain cell; Buffers; cell type; Cells; clinical phenotype; Complementary DNA; CpG dinucleotide; Cytolysis; Cytosine; design; Disease; DNA; DNA Methylation; DNA Transposable Elements; Epigenetic Process; epigenetic regulation; epigenetic variation; epigenome; epigenomics; flexibility; Functional disorder; Gel; Gene Expression; Gene Silencing; Generations; Genes; Genetic; Genome; genome sequencing; genome-wide; Genomic DNA; Goals; Heterogeneity; Hour; Human; Human Genome; imprint; in vivo; Individual; Inflammatory; Libraries; Ligation; Location; Malignant Neoplasms; Measures; Memory; Metabolic Diseases; Methods; Methylation; methylation pattern; methylome; Modification; Names; Nature; Neuronal Plasticity; Neurons; Nucleotides; Oligonucleotides; Play; Poly A; Poly T; Population; Positioning Attribute; Preparation; Process; Promoter Regions (Genetics); Protocols documentation; public health relevance; Ramp; Reagent; Regulation; Research Personnel; Role; single cell sequencing; Site; Solutions; Stretching; Synaptic Transmission; Tail; Technology; Time; Tissues; Transferase; Tube; Variant; X Inactivation

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
----
Phase II Amount
----